Sex steroids and all-cause and cause-specific mortality in men

Archives of Internal Medicine

Volumn 167, Issue 12, 2007, Pages 1252-1260

  Araujo, Andre B ^a   Kupelian, Varant ^a   Page, Stephanie T ^b   Handelsman, David J ^c   Bremner, William J ^b   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FOLLOW UP; HEART DEATH; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; CAUSE OF DEATH; DIHYDROTESTOSTERONE; FOLLOW-UP STUDIES; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; NEOPLASMS; RADIOIMMUNOASSAY; RESPIRATORY TRACT DISEASES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 34347211744     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.12.1252     Document Type: Article

References (49)

1. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87:589-598.
2. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724-731.
3. Araujo AB, O'Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89:5920-5926.
4. Harman SM. Testosterone in older men after the Institute of Medicine Report: where do we go from here? Climacteric. 2005;8:124-135.
5. Handelsman DJ. Trends and regional differences in testosterone prescribing in Australia, 1991-2001. Med J Aust. 2004;181:419-422.
6. Liverman CT, Blazer DG. Testosterone and Aging: Clinical Research Directions. Washington, DC: National Academies Press; 2004.
7. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006;166:1660-1665.
8. Bataille V, Perret B, Evans A, et al. Sex hormone-binding globulin is a major determinant of the lipid profile: the PRIME study. Atherosclerosis. 2005;179:369-373.
9. Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab. 2001;86:4078-4088.
10. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in non-obese men. J Clin Endocrinol Metab. 2006;91:843-850.
11. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts Male Aging Study. Diabetes Care. 2000;23:490-494.
12. O'Donnell AB, Araujo AB, McKinlay JB. The health of normally aging men: the Massachusetts Male Aging Study (1987-2004). Exp Gerontol. 2004;39:975-984.
13. McKinlay S, Kipp D, Johnson P, Downey K, Carelton R. A field approach for obtaining physiological measures in surveys of general populations: response rates, reliability and costs. In: Proceedings of the Fourth Conference on Health Survey Research Methods. Washington, DC: US Dept of Health and Human Services; 1984. Publication PHS 84-3346.
14. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983;56:1278-1281.
15. Brambilla DJ, McKinlay SM, McKinlay JB, et al. Does collecting repeated blood samples from each subject improve the precision of estimated steroid hormone levels? J Clin Epidemiol. 1996;49:345-350.
16. Södergård R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 β to human plasma proteins at body temperature. J Steroid Biochem. 1982;16:801-810.
17. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-3672.
18. Longcope C, Franz C, Morello C, Baker R, Johnston CC Jr. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas. 1986;8:189-196.
19. Bilgrad R. National Death Index Plus: Coded Causes of Death Supplement to the National Death Index User's Manual. Hyattsville, Md: National Center for Health Statistics, Centers for Disease Control and Prevention; 1997.
20. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
21. World Health Organization. International Statistical Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992.
22. Doody MM, Hayes HM, Bilgrad R. Comparability of National Death Index Plus and standard procedures for determining causes of death in epidemiologic studies. Ann Epidemiol. 2001;11:46-50.
23. Breslow NE, Day NE. The Design and Analysis of Cohort Studies: IARC Scientific Publications No. 82. Vol II. Lyon, France: International Agency for Research on Cancer; 1987. Statistical Methods in Cancer Research.
24. Amory JK, Chansky HA, Chansky KL, et al. Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery. J Am Geriatr Soc. 2002;50:1698-1701.
25. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation. 2005;112:332-340.
26. Dong Q, Hawker F, McWilliam D, Bangah M, Burger H, Handelsman DJ. Circulating immunoreactive inhibin and testosterone levels in men with critical illness. Clin Endocrinol (Oxf ). 1992;36:399-404.
27. Jeppesen LL, Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS, Winther K. Decreased serum testosterone in men with acute ischemic stroke. Arterioscler Thromb Vasc Biol. 1996;16:749-754.
28. Shores MM, Moceri VM, Gruenewald DA, Brodkin KI, Matsumoto AM, Kivlahan DR. Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit. J Am Geriatr Soc. 2004;52:2077-2081.
29. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24:313-340.
30. Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev. 2003;24:183-217.
31. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men: a prospective population-based study. Circulation. 1988;78:539-545.
32. Haffner SM, Moss SE, Klein BE, Klein R. Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 1996;19:1045-1050.
33. Goodman-Gruen D, Barrett-Connor E. A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women. J Clin Endocrinol Metab. 1996;81:2999-3003.
34. Kalme T, Seppala M, Qiao Q, et al. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab. 2005;90:1550-1556.
35. Bagatell CJ, Bremner WJ. Androgen and progestagen effects on plasma lipids. Prog Cardiovasc Dis. 1995;38:255-271.
36. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288-1299.
37. Smith MR, Lee H, Nathan DM. Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab. 2006;91:1305-1308.
38. Derby CA, Zilber S, Brambilla D, Morales K, McKinlay JB. Obesity, body composition and change in hormones with age: the Massachusetts Male Aging Study. Clin Endocrinol (Oxf ). 2006;65:125-131.
39. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349:215-224.
40. Pasquali R, Casimirri F, De Iasio R, et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab. 1995;80:654-658.
41. Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA. Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab. 2005;90:6516-6522.
42. Handelsman DJ, Liu PY. Klinefelter's syndrome: a microcosm of male reproductive health. J Clin Endocrinol Metab. 2006;91:1220-1222.
43. Van Vliet M, Spruit MA, Verleden G, et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:1105-1111.
44. Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab. 1994;79:1310-1316.
45. Creutzberg EC, Wouters EF, Mostert R, Pluymers RJ, Schols AM. A role for anabolic steroids in the rehabilitation of patients with COPD? a double-blind, placebo-controlled, randomized trial. Chest. 2003;124:1733-1742.
46. Svartberg J, Aasebo U, Hjalmarsen A, Sundsfjord J, Jorde R. Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial. Respir Med. 2004;98:906-913.
47. US Census Bureau. 1990 Census of Population and Housing, Summary Tape File 3C - part 1. http://venus.census.gov/cdrom/lookup. Accessed January 1, 2000.
48. Massachusetts Department of Public Health. Advance Data: Deaths, 1996. http://mass.gov/dph/bhsre/death/96/dth96c6.htm. Accessed March 1, 2006.
49. Ly LP, Handelsman DJ. Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol. 2005;152:471-478.